TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. However, the increasing risks of side-effects could pose a challenge to the growth of this market.
TechNavio's report, the Global Over-the-counter Pharmaceutical Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Over-the-counter Pharmaceutical market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Bayer Healthcare AG, Johnson & Johnson, GlaxoSmithKline plc, and Novartis International AG.
The other vendors mentioned in the report are Sanofi S.A., Reckitt Benckiser plc, Boehringer Ingelheim GmbH , Merck and Co. Inc., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Roche Holding Ltd., Procter and Gamble, Taisho Pharmaceutical, Bristol Myers Squibb Co., Schering-Plough Corp., Eisai Co. Ltd., Mitsubishi Tanabe Pharma Corp., Sigma Pharmaceuticals plc, Hubei Biocause Heilen Pharmaceutical Co. Ltd., United Laboratories Inc., Daewoong Pharmaceutical Co. Ltd., Bukwang Pharmaceutical Co. Ltd., Vida Laboratories Ltd., and Cipla Ltd.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?